MétaCan
Menu
Back to cohort
Record W4414530975 · doi:10.1186/s12913-025-13216-4

Electronic data sources for drug utilization research and healthcare decision-making in Mexico

2025· article· en· W4414530975 on OpenAlexaff
Yared Santa‐Ana‐Téllez, Anahí Dreser, Lucila I. Castro‐Pastrana, Maribel Salas, Juan Carlos Sánchez‐Salgado, Diana Lizbeth Gómez-Galicia, Lisiane Freitas Leal, Luciane Cruz Lopes

Bibliographic record

VenueBMC Health Services Research · 2025
Typearticle
Languageen
FieldPharmacology, Toxicology and Pharmaceutics
TopicPharmacovigilance and Adverse Drug Reactions
Canadian institutionsCentre Hospitalier Universitaire Sainte-Justine
FundersInstituto Mexicano del Seguro SocialInternational Society for Pharmacoepidemiology
KeywordsHealth informaticsNursing researchHealth administrationHealth carePublic healthHealth services researchHealth economicsDrug Utilization ReviewMEDLINE

Abstract

fetched live from OpenAlex

BACKGROUND: Understanding drug utilization is essential for informed decision-making in national healthcare and for enabling comparisons across countries. In Mexico, the limited research in this field may be attributed to the lack of awareness and accessibility of existing data sources. Addressing this gap requires a comprehensive inventory of data sources for Drug Utilization Research (DUR). The purpose of this study was to develop an inventory of electronic data sources available in Mexico for DUR, outlining their characteristics, strengths, and limitations. METHODS: From 2019 to 2024, specialists in pharmacoepidemiology and healthcare systems research conducted online searches for DUR data sources, including official websites of the Mexican government and public health institutions. A literature review was also performed for country-specific data sources in articles published between 2000 and 2023. Data sources were independently searched, screened, and selected by independent reviewers, with disagreements resolved through consensus. A descriptive analysis of selected databases was conducted, focusing on accessibility, geographical coverage, data aggregation level, health sector type, data source type, and setting. RESULTS: The analysis included twenty data sources, of which only four were publicly available. These databases offer insights into various aspects of drug utilization, primarily owned by social security institutions (twelve). Only four contain data from the private healthcare sector. Regarding data source type, five focused on procurement, twelve on prescription, two on pharmacovigilance, and one on drug disposal. CONCLUSIONS: Mexico faces notable challenges in accessible data for DUR especially in non-social security institutions and the private sector. This study underscores the urgent need to improve healthcare data accessibility and research in Mexico, to drive evidence-informed decision-making regarding medicines utilization.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.044
metaresearch head score (Gemma)0.138
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.052
Threshold uncertainty score0.234

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0440.138
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0520.061
Science and technology studies0.0020.001
Scholarly communication0.0050.006
Open science0.0030.004
Research integrity0.0020.001
Insufficient payload (model declined to judge)0.0090.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.402
GPT teacher head0.645
Teacher spread0.243 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueBMC Health Services ResearchSame topicPharmacovigilance and Adverse Drug ReactionsFrench-language works237,207